Open AccessHerpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis
Author(s) -
Beatrice Maranini,
Giovanni Ciancìo,
Rosario Cultrera,
Marcello Govoni
Publication year - 2021
Publication title -
reumatismo
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.294
H-Index - 25
eISSN - 2240-2683
pISSN - 0048-7449
DOI - 10.4081/reumatismo.2021.1445
Subject(s) - medicine , ankylosing spondylitis , outbreak , dermatology , virology , covid-19 , varicella zoster virus , coronavirus , immunology , virus , pathology , disease , infectious disease (medical specialty)
Since the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) pandemic outbreak, vaccines gained a growing role. Possible vaccine-related side effects range from minor local events to more prominent systemic manifestations up to anaphylactic reactions. A heterogeneous spectrum of cutaneous reactions has been reported, ranging from local injection site reactions to urticarial and morbilliform eruptions, pernio/chilblains and zoster flares. Here, we describe a case of varicella zoster virus reactivation following mRNA coronavirus 2019 vaccine and discuss the available literature upon the topic published so far.